Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Department of Infection Biology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK; Department of Experimental Cardiology, University Medical Center Utrecht, Netherlands.
Int J Cardiol. 2021 Apr 15;329:130-135. doi: 10.1016/j.ijcard.2020.12.065. Epub 2021 Jan 2.
To validate a novel artificial-intelligence electrocardiogram algorithm (AI-ECG) to detect left ventricular systolic dysfunction (LVSD) in an external population.
LVSD, even when asymptomatic, confers increased morbidity and mortality. We recently derived AI-ECG to detect LVSD using ECGs based on a large sample of patients treated at the Mayo Clinic.
We performed an external validation study with subjects from the Know Your Heart Study, a cross-sectional study of adults aged 35-69 years residing in two cities in Russia, who had undergone both ECG and transthoracic echocardiography. LVSD was defined as left ventricular ejection fraction ≤ 35%. We assessed the performance of the AI-ECG to identify LVSD in this distinct patient population.
Among 4277 subjects in this external population-based validation study, 0.6% had LVSD (compared to 7.8% of the original clinical derivation study). The overall performance of the AI-ECG to detect LVSD was robust with an area under the receiver operating curve of 0.82. When using the LVSD probability cut-off of 0.256 from the original derivation study, the sensitivity, specificity, and accuracy in this population were 26.9%, 97.4%, 97.0%, respectively. Other probability cut-offs were analysed for different sensitivity values.
The AI-ECG detected LVSD with robust test performance in a population that was very different from that used to develop the algorithm. Population-specific cut-offs may be necessary for clinical implementation. Differences in population characteristics, ECG and echocardiographic data quality may affect test performance.
验证一种新的人工智能心电图算法(AI-ECG)在外部人群中检测左心室收缩功能障碍(LVSD)的能力。
LVSD 即使没有症状,也会增加发病率和死亡率。我们最近开发了一种 AI-ECG 算法,通过基于在 Mayo 诊所接受治疗的大量患者的心电图来检测 LVSD。
我们进行了一项外部验证研究,研究对象来自俄罗斯两个城市的 Know Your Heart 研究,这是一项横断面研究,研究对象为年龄在 35-69 岁的成年人,他们都接受了心电图和经胸超声心动图检查。LVSD 的定义为左心室射血分数≤35%。我们评估了 AI-ECG 在这个独特的患者群体中识别 LVSD 的性能。
在这项基于外部人群的验证研究中,4277 名受试者中,有 0.6%(相比之下,原始临床推导研究中有 7.8%)患有 LVSD。AI-ECG 检测 LVSD 的整体性能稳健,接受者操作特征曲线下面积为 0.82。当使用原始推导研究中的 LVSD 概率截断值 0.256 时,该算法在该人群中的敏感性、特异性和准确性分别为 26.9%、97.4%和 97.0%。还分析了其他概率截断值,以获得不同的敏感性值。
AI-ECG 在与开发算法非常不同的人群中检测 LVSD 的性能稳健。可能需要针对特定人群的截断值来进行临床实施。人群特征、心电图和超声心动图数据质量的差异可能会影响测试性能。